ASLAN Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- ASLAN Pharmaceuticals's estimated annual revenue is currently $10.7M per year.
- ASLAN Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- ASLAN Pharmaceuticals has 53 Employees.
- ASLAN Pharmaceuticals grew their employee count by 6% last year.
ASLAN Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | VP Clinical Development & Operations | Reveal Email/Phone |
3 | VP, Head Medical | Reveal Email/Phone |
4 | General Counsel | Reveal Email/Phone |
5 | VP Business Development | Reveal Email/Phone |
6 | Associate Medical Director | Reveal Email/Phone |
7 | Executive Director, Head Translational Sciences | Reveal Email/Phone |
8 | Senior Director R&D | Reveal Email/Phone |
9 | Director, Investor Relations and Scientific/ Corporate Communications | Reveal Email/Phone |
10 | Chief Business Officer | Reveal Email/Phone |
ASLAN Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 22 | N/A | N/A | N/A |
#2 | $10.7M | 53 | 6% | N/A | N/A |
#3 | $3M | 15 | 15% | N/A | N/A |
#4 | $12.9M | 64 | 5% | N/A | N/A |
#5 | $1330M | 6617 | 7% | N/A | N/A |
What Is ASLAN Pharmaceuticals?
ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. Led by a senior management team with extensive experience in global development and commercialisation, ASLAN has a clinical portfolio comprised of a first-in-class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology. ASLAN's partners include Almirall, Array BioPharma, Bristol-Myers Squibb, and CSL.
keywords:N/A
N/A
Total Funding
53
Number of Employees
$10.7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ASLAN Pharmaceuticals News
ASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to...
ASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to...
and SINGAPORE, March 28, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical...
Other Companies in Singapore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.6M | 53 | 33% | N/A |
#2 | $6.7M | 53 | -2% | N/A |
#3 | $7.2M | 53 | 36% | N/A |
#4 | $11.9M | 53 | N/A | N/A |
#5 | $7.8M | 54 | -22% | N/A |